28 results
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
to any of the foregoing and all proposed labels, labelling, package inserts, monographs and packaging for a Licensed Product in a particular country
8-K
ddz2j07 pm89
17 Dec 19
EyeGate Pharma Receives $1.9 Million From Exercised Warrants
8:41am
8-K
EX-99.1
6z8lg5gz794u9zyp op
17 Dec 19
EyeGate Pharma Receives $1.9 Million From Exercised Warrants
8:41am
8-K
EX-99.1
mqz8f2wbavxvcr
2 Dec 19
EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
6:55am
8-K
EX-99.1
oqfmx bwcqipdg22
22 Nov 19
Other Events
6:55am
8-K
EX-10.1
tpc7st9e04 11q9z5357
10 Jul 15
EyeGate Signs Licensing Agreement with Valeant Pharmaceuticals for EGP-437 Combination Product in Uveitis
12:00am
10-K
nztd0 of9yi06iec5
31 Mar 15
Annual report
12:00am
424B4
h8tjvlybtopvhj3
13 Feb 15
Prospectus supplement with pricing info
12:00am
FWP
vqdn91q
16 Jan 15
Free writing prospectus
12:00am